Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Am J Kidney Dis. 2021 Apr 9;78(1):103–115. doi: 10.1053/j.ajkd.2021.03.008

Box 1.

Overview of Work Phases and Activities of the NKF-ASN Task Force

Phase 1
  • Clarifying the problem and evidence
    • eGFR and measurement
  • Race, racism, and genetic ancestry
    • Body composition and populations used in GFR estimation
    • Standardization and guidelines
    • Patients’ perspective and shared decision making
  • Possible approaches to address race in GFR estimation (Box 3)

Phase 2
  • Evaluating the approaches
    • Clinical consequences of different approaches
    • System and societal consequences of different approaches
Phase 3
  • Making recommendations
    • Issuance of recommendations
    • Comment on recommendations
    • Implementation